Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Jeffrey Stuart Brown, Ph.D.

Co-Author

This page shows the publications co-authored by Jeffrey Brown and Richard Platt.
Connection Strength

3.786
  1. Distributed health data networks: a practical and preferred approach to multi-institutional evaluations of comparative effectiveness, safety, and quality of care. Med Care. 2010 Jun; 48(6 Suppl):S45-51.
    View in: PubMed
    Score: 0.438
  2. Active influenza vaccine safety surveillance: potential within a healthcare claims environment. Med Care. 2009 Dec; 47(12):1251-7.
    View in: PubMed
    Score: 0.423
  3. Early adverse drug event signal detection within population-based health networks using sequential methods: key methodologic considerations. Pharmacoepidemiol Drug Saf. 2009 Mar; 18(3):226-34.
    View in: PubMed
    Score: 0.402
  4. Early detection of adverse drug events within population-based health networks: application of sequential testing methods. Pharmacoepidemiol Drug Saf. 2007 Dec; 16(12):1275-84.
    View in: PubMed
    Score: 0.369
  5. Incidence of statin use in older adults with and without cardiovascular disease and diabetes mellitus, January 2008- March 2018. PLoS One. 2019; 14(12):e0223515.
    View in: PubMed
    Score: 0.212
  6. Cancer Screening Results and Follow-up Using Routinely Collected Electronic Health Data: Estimates for Breast, Colon, and Cervical Cancer Screenings. J Gen Intern Med. 2019 03; 34(3):341-343.
    View in: PubMed
    Score: 0.201
  7. The FDA Sentinel Initiative - An Evolving National Resource. N Engl J Med. 2018 Nov 29; 379(22):2091-2093.
    View in: PubMed
    Score: 0.197
  8. Launching PCORnet, a national patient-centered clinical research network. J Am Med Inform Assoc. 2014 Jul-Aug; 21(4):578-82.
    View in: PubMed
    Score: 0.144
  9. Drug safety data mining with a tree-based scan statistic. Pharmacoepidemiol Drug Saf. 2013 May; 22(5):517-23.
    View in: PubMed
    Score: 0.133
  10. Risk of Guillain-Barré syndrome after meningococcal conjugate vaccination. Pharmacoepidemiol Drug Saf. 2012 Dec; 21(12):1350-8.
    View in: PubMed
    Score: 0.127
  11. The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf. 2012 Jan; 21 Suppl 1:1-8.
    View in: PubMed
    Score: 0.122
  12. Developing the Sentinel System--a national resource for evidence development. N Engl J Med. 2011 Feb 10; 364(6):498-9.
    View in: PubMed
    Score: 0.114
  13. Outpatient urticaria diagnosis codes have limited predictive value for same-day influenza vaccine adverse event detection. J Clin Epidemiol. 2010 Apr; 63(4):407-11.
    View in: PubMed
    Score: 0.105
  14. Design of a national distributed health data network. Ann Intern Med. 2009 Sep 01; 151(5):341-4.
    View in: PubMed
    Score: 0.103
  15. Potential population-based electronic data sources for rapid pandemic influenza vaccine adverse event detection: a survey of health plans. Pharmacoepidemiol Drug Saf. 2008 Dec; 17(12):1137-41.
    View in: PubMed
    Score: 0.099
  16. A distributed research network model for post-marketing safety studies: the Meningococcal Vaccine Study. Pharmacoepidemiol Drug Saf. 2008 Dec; 17(12):1226-34.
    View in: PubMed
    Score: 0.099
  17. Outpatient use of cardiovascular drugs during pregnancy. Pharmacoepidemiol Drug Saf. 2008 Mar; 17(3):240-7.
    View in: PubMed
    Score: 0.094
  18. Use of antidepressant medications during pregnancy: a multisite study. Am J Obstet Gynecol. 2008 Feb; 198(2):194.e1-5.
    View in: PubMed
    Score: 0.091
  19. A COVID-19-ready public health surveillance system: The Food and Drug Administration's Sentinel System. Pharmacoepidemiol Drug Saf. 2021 07; 30(7):827-837.
    View in: PubMed
    Score: 0.058
  20. Leveraging the Capabilities of the FDA's Sentinel System To Improve Kidney Care. J Am Soc Nephrol. 2020 11; 31(11):2506-2516.
    View in: PubMed
    Score: 0.056
  21. Considerations for using distributed research networks to conduct aspects of randomized trials. Contemp Clin Trials Commun. 2020 Mar; 17:100515.
    View in: PubMed
    Score: 0.053
  22. How pharmacoepidemiology networks can manage distributed analyses to improve replicability and transparency and minimize bias. Pharmacoepidemiol Drug Saf. 2019 Jan 15.
    View in: PubMed
    Score: 0.050
  23. MDPHnet: secure, distributed sharing of electronic health record data for public health surveillance, evaluation, and planning. Am J Public Health. 2014 Dec; 104(12):2265-70.
    View in: PubMed
    Score: 0.037
  24. Rapid assessment of cardiovascular risk among users of smoking cessation drugs within the US Food and Drug Administration's Mini-Sentinel program. JAMA Intern Med. 2013 May 13; 173(9):817-9.
    View in: PubMed
    Score: 0.034
  25. Real-time vaccine safety surveillance for the early detection of adverse events. Med Care. 2007 Oct; 45(10 Supl 2):S89-95.
    View in: PubMed
    Score: 0.023
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.